Coartem™ (Artemether-lumefantrine combination)
516/CNBS/2017
Approved small_molecule completed
Quick answer
Coartem™ (Artemether-lumefantrine combination) for Malaria is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Malaria
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed